SCHEMBL16638722

SCHEMBL16638722

Cc1cc([N+](=O)[O-])ccc1Nc1ncccc1/C=C/C(=O)c1cccnc1Nc1ccc([N+](=O)[O-])cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.46
▸ RAB9A P51151 5/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ HPGD P15428 1/20 0.46
▸ MAPT P10636 9/20 0.45
▸ NPC1 O15118 4/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ HTT P42858 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16627417 0.89 MAPT (0.44) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16638724 0.84 ALDH1A1 (0.50) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16638390 0.84 RAB9A (0.42) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16638723 0.83 RAB9A (0.67) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16638725 0.83 ALDH1A1 (0.49) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16627424 0.83 ALDH1A1 (0.53) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16627421 0.82 MEN1 (0.44) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16638721 0.82 ALDH1A1 (0.47) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16616675 0.81 SMN1; SMN2 (0.44) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT
SCHEMBL16616672 0.81 SMN1; SMN2 (0.44) ALDH1A1RAB9ASMN1; SMN2HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 — — US disclosed
Send feedback